REGENXBIO Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-263.49	-280.32	127.84	-111.25	-94.73	99.94	-73.17	-62.97	-23.8	-4.82	Upgrade
Depreciation & Amortization	17.32	12.91	9.56	8.41	7.15	3.98	2.69	0.54	0.08	0	Upgrade
Share-Based Compensation	40.27	40.79	38.81	31.95	26.85	16.64	10.61	7.03	2.92	0.32	Upgrade
Other Operating Activities	-12.5	19.14	42.66	16.83	-46.98	-15.91	1.89	6.83	-2.71	1.29	Upgrade
Operating Cash Flow	-218.41	-207.49	218.88	-54.06	-107.71	104.65	-57.99	-48.56	-22.52	-2.4	Upgrade
Capital Expenditures	-9.96	-30.72	-84.18	-26.87	-11.72	-13.28	-7.16	-8.15	-0.52	0	Upgrade
Change in Investments	200.9	18.8	-322.47	149.63	105.28	-266.08	2.37	27.54	-163.28	0	Upgrade
Investing Cash Flow	190.94	-11.93	-406.64	122.76	93.56	-279.36	-4.79	19.39	-163.8	0	Upgrade
Share Issuance / Repurchase	8.22	4.55	222.49	7.42	8.38	205.06	85.04	0.18	145.29	0	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	0	0	2.4	Upgrade
Other Financing Activities	-43.19	-33.39	-27.24	192.79	-	-0.62	-0.45	-0.06	94.02	-	Upgrade
Financing Cash Flow	-34.97	-28.84	195.25	200.21	8.38	204.44	84.6	0.12	239.31	2.4	Upgrade
Net Cash Flow	-62.43	-248.26	7.48	268.91	-5.77	29.73	21.82	-29.05	53	0	Upgrade
Free Cash Flow	-228.37	-238.21	134.7	-80.93	-119.43	91.37	-65.15	-56.71	-23.04	-2.4	Upgrade
Free Cash Flow Margin	-253.06%	-211.32%	28.64%	-52.36%	-338.96%	41.82%	-626.88%	-1235.72%	-303.60%	-39.20%	Upgrade
Free Cash Flow Per Share	-5.22	-5.52	3.17	-2.17	-3.25	2.73	-2.18	-2.15	-2.51	-0.91	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).